Promising Tilray clinical trials, Ayr's winning strategy, and momentum in Michigan lead the news this week...

You must subscribe to NICI Membership Lifetime to view this content. To learn more and access special member pricing contact our VIP team at 1-866-298-7257. 

Sign In

Enter your details below.